New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for Clinicians

Although tuberculosis (TB) is preventable and curable, the lengthy treatment (generally 6 months), poor patient adherence, high inter-individual variability in pharmacokinetics (PK), emergence of drug resistance, presence of comorbidities, and adverse drug reactions complicate TB therapy and drive t...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilar Diaz, Jessica M, Abulfathi, Ahmed A, te Brake, Lindsey HM, van Ingen, Jakko, Kuipers, Saskia, Magis-Escurra, Cecile, Raaijmakers, Jelmer, Svensson, Elin M, Boeree, Martin J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Thematic Review Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932851/
https://www.ncbi.nlm.nih.gov/pubmed/36516792
http://dx.doi.org/10.1159/000528274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932851/
https://www.ncbi.nlm.nih.gov/pubmed/36516792
http://dx.doi.org/10.1159/000528274

Ejemplares similares